You may be wondering whether there is any way to slow down the disease, make symptoms milder, or even prevent them. AD researchers are working to find answers to these questions, and need your help.
The VALID Study (VALproate In Dementia)
research has shown that Valproate, an anticonvulsant drug, may be
helpful in slowing AD and some of its symptoms. The VALID study is another step
toward finding out. This study will test whether Valproate is effective in
delaying, weakening, or preventing difficult behaviors in people with early
stage AD, and whether it has any effect on slowing the progression of AD
VALID is sponsored by the Alzheimer’s Disease Cooperative Study based at the University of California, San Diego and funded by the U.S. Government’s National Institute on Aging, one of the National Institutes of Health.
VALID Study Seeks Participants at 30 Sites Nationwide
this study are looking for participants who:
§ are age 55-90,
§ have been diagnosed with probable Alzheimer’s disease (AD), and
§ have not experienced agitation or psychosis since the onset of AD.
Participants must also have a study partner who can provide informed consent to participate and is willing and able to attend all clinic visits to report on the study participant’s activities and behavior.
Study participants will be assigned at random
to receive Valproate or placebo (inactive pill), and will be regularly
monitored during the 26-month research study by physicians and qualified health
care professionals who specialize in dementia.
For More Information: Call
Alena Kleytman at (650) 493-5000 ext. 64184